CAPRICOR THERAPEUTICS INC. - COMMON STOCK

Capricor Therapeutics to Participate in Upcoming Investor Conferences

10 2 2025 08:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

02 1 2025 08:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor Conferences

02 12 2024 15:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

20 11 2024 08:00:01 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

13 11 2024 15:01:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

12 11 2024 08:00:01 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

05 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

18 10 2024 15:01:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

17 10 2024 05:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

16 10 2024 15:17:48 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

15 10 2024 11:27:21 提供 NetDania Notify

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

11 10 2024 08:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

09 10 2024 08:15:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

04 10 2024 08:47:23 提供 NetDania Notify

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

04 10 2024 08:15:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

01 10 2024 08:48:05 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

30 9 2024 10:30:56 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

25 9 2024 08:45:14 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

24 9 2024 08:45:18 提供 NetDania Notify

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

24 9 2024 07:00:01 提供 Nasdaq GlobeNewswire